Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
35.2M
-
Shares change
-
+3.17M
-
Total reported value, excl. options
-
$571M
-
Value change
-
+$57.3M
-
Put/Call ratio
-
0.16
-
Number of buys
-
60
-
Number of sells
-
-43
-
Price
-
$16.25
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q1 2014
140 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q1 2014.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.2M shares
of 58.9M outstanding shares and own 59.72% of the company stock.
Largest 10 shareholders include FMR LLC (4.52M shares), BAKER BROS. ADVISORS LP (4.45M shares), Palo Alto Investors, LLC (3.22M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.75M shares), State Street Corp (1.55M shares), Invesco Ltd. (1.48M shares), PAULSON & CO INC (1.39M shares), BlackRock Fund Advisors (1.34M shares), Consonance Capital Management LP (1.23M shares), and KINGDON CAPITAL MANAGEMENT, L.L.C. (1.15M shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.